SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.32 CNY | +0.14% |
|
-2.53% | -8.50% |
| May. 14 | GRIFOLS CEO SAYS CAN CONFIRM SHANGHAI RAAS TRANSACTION WILL CLO… | RE |
| Apr. 29 | Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Shanghai RAAS Blood Products Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.71% | 2 M€ | -14.14% | ||
| 0.69% | 2 M€ | -14.64% | - | |
| 0.05% | 35 M€ | -5.85% | - | |
| 0.04% | 11 M€ | +7.20% | ||
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 112 M€ | +5.47% | - | |
| 0.00% | 454 M€ | +8.61% | - | |
| 0.00% | 2,867 M€ | +10.35% | - | |
| 0.00% | 153 M€ | +8.19% | - | |
| 0.00% | 32 M€ | +8.70% | - | |
| 0.00% | 391 M€ | +9.24% | - | |
| 0.00% | 34 M€ | +9.50% | - | |
| 0.00% | 34 M€ | +4.77% | - | |
| 0.00% | 39 M€ | +6.45% | - | |
| 0.00% | 306 M€ | +6.36% | - | |
| 0.00% | 17 M€ | +3.36% | - | |
| 0.00% | 105 M€ | +4.03% | - | |
| 0.00% | 7 M€ | +6.42% | - | |
| 0.00% | 54 M€ | +1.29% | - | |
| 0.00% | 15 M€ | +19.58% | ||
| 0.00% | 8 M€ | +0.94% | - |
Shanghai RAAS Blood Products Co., Ltd. specializes in the research, development and manufacturing of plasma-derived therapeutics. The group's products include human albumin, immunoglobulin and coagulation factors (thrombin, fibrinogen, prothrombin and fibrin).
China accounts for 96.6% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
7.32
CNY
Average target price
6
CNY
Spread / Average Target
-18.03%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.50% | 6.68B | |
| -2.65% | 89.49B | |
| +2.50% | 40.67B | |
| -12.01% | 33.15B | |
| +62.74% | 26.45B | |
| -19.79% | 14.69B | |
| -8.58% | 12.89B | |
| -12.34% | 11.54B | |
| -43.92% | 11.34B | |
| +4.27% | 8.84B |
- Stock Market
- Equities
- 002252 Stock
- Funds and ETFs Shanghai RAAS Blood Products Co., Ltd.
